array:24 [
  "pii" => "S0001731018303454"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2017.11.021"
  "estado" => "S300"
  "fechaPublicacion" => "2019-01-01"
  "aid" => "2026"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2018"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2019;110:43-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 343
    "formatos" => array:2 [
      "HTML" => 157
      "PDF" => 186
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S1578219018304116"
      "issn" => "15782190"
      "doi" => "10.1016/j.adengl.2018.11.013"
      "estado" => "S300"
      "fechaPublicacion" => "2019-01-01"
      "aid" => "2026"
      "copyright" => "Elsevier España, S.L.U. and AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2019;110:43-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2
        "HTML" => 2
      ]
      "en" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Brief Comunication</span>"
        "titulo" => "Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab&#58; First Case Reported With Isolated Cutaneous Findings"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "43"
            "paginaFinal" => "49"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Reacci&#243;n granulomatosa en paciente con melanoma metast&#225;sico tratado con ipilimumab&#58; primer caso descrito presentando cl&#237;nica cut&#225;nea &#250;nicamente"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figure 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 1513
                "Ancho" => 1000
                "Tamanyo" => 528812
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Pathology findings&#46; Epidermal thinning with irregular acanthosis&#44; discrete spongiosis&#44; and parakeratosis&#46; The papillary dermis is replaced almost entirely by granulomas &#40;A&#41; and granulomatous reaction with prominent macrophages and giant cells &#40;B&#41;&#46; &#40;Hematoxylin and eosin&#44; x10&#46;&#41;&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "J&#46; Cervantes, A&#46; Rosen, L&#46; Dehesa, G&#46; Dickinson, J&#46; Alonso-Llamazares"
            "autores" => array:5 [
              0 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Cervantes"
              ]
              1 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Rosen"
              ]
              2 => array:2 [
                "nombre" => "L&#46;"
                "apellidos" => "Dehesa"
              ]
              3 => array:2 [
                "nombre" => "G&#46;"
                "apellidos" => "Dickinson"
              ]
              4 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Alonso-Llamazares"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0001731018303454"
          "doi" => "10.1016/j.ad.2017.11.021"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018303454?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304116?idApp=UINPBA000044"
      "url" => "/15782190/0000011000000001/v1_201901030631/S1578219018304116/v1_201901030631/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731017306051"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2017.06.024"
    "estado" => "S300"
    "fechaPublicacion" => "2019-01-01"
    "aid" => "1849"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2019;110:50-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 343
      "formatos" => array:2 [
        "HTML" => 144
        "PDF" => 199
      ]
    ]
    "es" => array:14 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">COMUNICACI&#211;N BREVE</span>"
      "titulo" => "Epiderm&#243;lisis bullosa distr&#243;fica recesiva y embarazo"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:3 [
        0 => "es"
        1 => "es"
        2 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "50"
          "paginaFinal" => "52"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Recessive Dystrophic Epidermolysis Bullosa and Pregnancy"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 1
        "multimedia" => array:5 [
          "identificador" => "fig0015"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => false
          "mostrarDisplay" => true
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "fx1.jpeg"
              "Alto" => 514
              "Ancho" => 1333
              "Tamanyo" => 124894
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F&#46; Boria, R&#46; Maseda, M&#46; Mart&#237;n-Came&#225;n, M&#46; De la Calle, R&#46; de Lucas"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Boria"
            ]
            1 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Maseda"
            ]
            2 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Mart&#237;n-Came&#225;n"
            ]
            3 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "De la Calle"
            ]
            4 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "de Lucas"
            ]
          ]
        ]
      ]
      "resumen" => array:1 [
        0 => array:3 [
          "titulo" => "Graphical abstract"
          "clase" => "graphical"
          "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>"
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219018304001"
        "doi" => "10.1016/j.adengl.2018.11.004"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304001?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306051?idApp=UINPBA000044"
    "url" => "/00017310/0000011000000001/v1_201901030610/S0001731017306051/v1_201901030610/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0001731018303971"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2018.09.003"
    "estado" => "S300"
    "fechaPublicacion" => "2019-01-01"
    "aid" => "2050"
    "copyright" => "AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2019;110:38-42"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1088
      "formatos" => array:2 [
        "HTML" => 310
        "PDF" => 778
      ]
    ]
    "es" => array:14 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">ORIGINAL</span>"
      "titulo" => "Aislamiento de <span class="elsevierStyleItalic">Haemophilus</span> spp&#46; en exudados uretrales como posible agente etiol&#243;gico de uretritis aguda&#58; estudio de 38 casos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:3 [
        0 => "es"
        1 => "es"
        2 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "38"
          "paginaFinal" => "42"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "<span class="elsevierStyleItalic">Haemophilus</span> Species Isolated in Urethral Exudates as a Possible Causative Agent in Acute Urethritis&#58; A Study of 38 Cases"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 1
        "multimedia" => array:5 [
          "identificador" => "fig0015"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => false
          "mostrarDisplay" => true
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "fx1.jpeg"
              "Alto" => 1085
              "Ancho" => 1315
              "Tamanyo" => 71523
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46; Magdaleno-Tapial, C&#46; Valenzuela-O&#241;ate, M&#46;M&#46; Giacaman-von der Weth, B&#46; Ferrer-Guill&#233;n, &#193;&#46; Mart&#237;nez-Domenech, M&#46; Garc&#237;a-Legaz Mart&#237;nez, J&#46;M&#46; Ortiz-Salvador, D&#46; Subiabre-Ferrer, P&#46; Hern&#225;ndez-Bel"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Magdaleno-Tapial"
            ]
            1 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Valenzuela-O&#241;ate"
            ]
            2 => array:2 [
              "nombre" => "M&#46;M&#46;"
              "apellidos" => "Giacaman-von der Weth"
            ]
            3 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Ferrer-Guill&#233;n"
            ]
            4 => array:2 [
              "nombre" => "&#193;&#46;"
              "apellidos" => "Mart&#237;nez-Domenech"
            ]
            5 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Garc&#237;a-Legaz Mart&#237;nez"
            ]
            6 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Ortiz-Salvador"
            ]
            7 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Subiabre-Ferrer"
            ]
            8 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Hern&#225;ndez-Bel"
            ]
          ]
        ]
      ]
      "resumen" => array:1 [
        0 => array:3 [
          "titulo" => "Graphical abstract"
          "clase" => "graphical"
          "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>"
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219018304098"
        "doi" => "10.1016/j.adengl.2018.11.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304098?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018303971?idApp=UINPBA000044"
    "url" => "/00017310/0000011000000001/v1_201901030610/S0001731018303971/v1_201901030610/es/main.assets"
  ]
  "es" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">COMUNICACI&#211;N BREVE</span>"
    "titulo" => "Reacci&#243;n granulomatosa en paciente con melanoma metast&#225;sico tratado con ipilimumab&#58; primer caso descrito presentando cl&#237;nica cut&#225;nea &#250;nicamente"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "43"
        "paginaFinal" => "49"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "J&#46; Cervantes, A&#46; Rosen, L&#46; Dehesa, G&#46; Dickinson, J&#46; Alonso-Llamazares"
        "autores" => array:5 [
          0 => array:4 [
            "nombre" => "J&#46;"
            "apellidos" => "Cervantes"
            "email" => array:1 [
              0 => "J&#46;Cervantes1&#64;umiami&#46;edu"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Rosen"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "L&#46;"
            "apellidos" => "Dehesa"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "G&#46;"
            "apellidos" => "Dickinson"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "J&#46;"
            "apellidos" => "Alonso-Llamazares"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Departamento de Dermatolog&#237;a y Cirug&#237;a Cut&#225;nea&#44; Facultad de Medicina&#44; Universidad Miller de Miami&#44; Miami&#44; Florida&#44; Estados Unidos"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Centro M&#233;dico San Francisco&#44; Universidad de California&#44; San Francisco&#44; California&#44; Estados Unidos"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Departamento de Enfermedades Infecciosas&#44; Facultad de Medicina&#44; Universidad Miller de Miami&#44; Miami&#44; Florida&#44; Estados Unidos"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab&#58; First Case Reported With Isolated Cutaneous Findings"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 1
      "multimedia" => array:5 [
        "identificador" => "fig0015"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "fx1.jpeg"
            "Alto" => 1025
            "Ancho" => 1333
            "Tamanyo" => 90988
          ]
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Caso cl&#237;nico</span><p id="par0005" class="elsevierStylePara elsevierViewall">Un var&#243;n de 67 a&#241;os acudi&#243; a la consulta de dermatolog&#237;a por prurito generalizado de leve intensidad de seis meses de evoluci&#243;n&#44; acompa&#241;ado de m&#250;ltiples lesiones papulosas&#44; coalescentes&#44; localizadas inicialmente en espalda&#44; pero que posteriormente se extienden r&#225;pidamente hacia rostro&#44; extremidades superiores e inferiores&#44; dorso de manos y pies&#44; ingle y caderas&#46; Entre los antecedentes patol&#243;gicos cabe mencionar el diagn&#243;stico de melanoma metast&#225;sico &#40;estadio IV&#41;&#46; El tumor primario hab&#237;a sido diagnosticado en la piel lumbar&#44; y adem&#225;s el paciente presentaba met&#225;stasis en el pulm&#243;n&#44; el h&#237;gado y en ganglios linf&#225;ticos retroperitoneales&#46; Gracias al tratamiento con ipilulumab el paciente se encontraba en remisi&#243;n completa desde hac&#237;a dos a&#241;os&#46; El ipilimumab se paut&#243; inicialmente a altas dosis &#40;10<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; cada 3 semanas por 4 ciclos &#40;fase de inducci&#243;n&#41; y posteriormente se pas&#243; a pauta de una infusi&#243;n cada 3 meses &#40;fase de mantenimiento&#41;&#46; El paciente present&#243; sequedad&#44; alopecia y vit&#237;ligo como efectos adversos en relaci&#243;n con el ipilimumab&#59; todos fueron de primer grado&#44; por lo que no fue necesario disminuir la dosis&#46; Adem&#225;s del ipilimumab&#44; el paciente se encontraba en tratamiento con venlafaxina&#44; olmesart&#225;n&#44; fexofenadina y ranitidina&#46; No se conoc&#237;a la existencia de alguna alergia medicamentosa&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Al examen cl&#237;nico se evidenciaron m&#250;ltiples p&#225;pulas inflamatorias agrupadas&#44; de aspecto costroso&#44; distribuidas sim&#233;tricamente a nivel de rostro &#40;a predominio de surcos nasolabiales&#44; arcos supraciliares y glabela&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>a&#41;&#44; as&#237; como en cuello&#44; orejas&#44; cuero cabelludo&#44; ingles&#44; espalda&#44; caderas &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>b&#41;&#44; codos&#44; mu&#241;ecas y tobillos &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>c&#41;&#46; Anal&#237;ticamente&#44; tanto la bioqu&#237;mica sangu&#237;nea&#44; el hemograma&#44; el calcio urinario&#44; como la ECA&#44; se encontraban dentro de la normalidad&#46; Los cultivos para micobacterias&#44; bacterias y hongos fueron negativos&#44; as&#237; como el PPD y el RPR&#46; Tanto la radiograf&#237;a de t&#243;rax como el PET-TAC no mostraban hallazgos patol&#243;gicos&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Se decidi&#243; biopsiar las lesiones&#46; La histopatolog&#237;a mostraba a nivel de dermis superficial la presencia de granulomas nodulares epitelioides rodeados por linfocitos T&#46; Por otro lado se evidenciaban &#225;reas con epidermotropismo linfoc&#237;tico&#44; compatibles con una dermatitis granulomatosa &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a> a y b&#41;&#46; Se objetivaban escasos linfocitos B CD20 positivo&#44; y el CD30&#44; CD56&#44; CD1a y S100 fueron negativos&#46; El CD58 fue positivo para c&#233;lulas gigantes y de igual forma para algunos macr&#243;fagos&#46; La mayor&#237;a de los linfocitos del infiltrado se marcaban con CD3&#44; CD4 y CD7&#46; La relaci&#243;n CD4&#58;CD8 fue de 2&#58;1&#46; PAS&#44; GMS&#44; giemsa&#44; gram y Fite fueron negativos&#46; Tinciones espec&#237;ficas para treponema de igual forma fueron negativas&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Ante los hallazgos cl&#237;nicos e histol&#243;gicos se lleg&#243; al diagn&#243;stico de una dermatitis granulomatosa secundaria al ipilimumab&#46; Se inici&#243; tratamiento con prednisona v&#237;a oral&#44; a una dosis de 60<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; con lo que el paciente mejor&#243; inicialmente&#46; Sin embargo&#44; tras pauta descendente de predmisona&#44; las lesiones empeoraron&#46; Se pautaron corticoides v&#237;a intramuscular y t&#243;pica&#44; con lo que el paciente present&#243; una mejor&#237;a cl&#237;nica relativa&#46; En consenso con oncolog&#237;a&#44; se decide suspender el tratamiento con ipilimumab&#46; Seis meses despu&#233;s de haber suspendido el tratamiento&#44; las lesiones cut&#225;neas se resolvieron completamente&#46; No fue necesario pautar medicaci&#243;n complementaria&#46; En el &#250;ltimo control&#44; el paciente se encontraba asintom&#225;tico y bajo seguimiento tanto por oncolog&#237;a como por dermatolog&#237;a con la finalidad de detectar precozmente la presencia de recidiva tumoral&#59; para lo cual se realiza un PET-TAC cada tres meses as&#237; como visitas de seguimiento cada tres a seis meses&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discusi&#243;n</span><p id="par0025" class="elsevierStylePara elsevierViewall">Las dermatosis granulomatosas se caracterizan por presentar un infiltrado inflamatorio predominantemente d&#233;rmico&#44; reactivo&#44; no neopl&#225;sico&#44; compuesto principalmente por macr&#243;fagos tisulares &#40;histiocitos&#41;&#44; c&#233;lulas epitelioides&#44; as&#237; como por c&#233;lulas gigantes multinucleadas<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">1</span></a>&#46; Los granulomas de etiolog&#237;a no infecciosa se pueden observar en el granuloma anular&#44; el granuloma anular elastol&#237;tico de c&#233;lulas gigantes&#44; la necrobiosis lipo&#237;dica&#44; la dermatitis granulomatosa intersticial&#44; la reacci&#243;n granulomatosa intersticial medicamentosa&#44; la sarcoidosis&#44; las reacciones a cuerpo extra&#241;o&#44; as&#237; como en neoplasias malignas &#40;ej&#46; micosis fungoides&#44; s&#237;ndrome de S&#233;zary&#44; enfermedad de Hodgkin&#44; leucemia linf&#225;tica cr&#243;nica B&#44; melanoma y otras neoplasias &#91;pulm&#243;n&#44; mama&#44; etc&#46;&#93;&#41; entre otras<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">2</span></a>&#46; Debido a la superposici&#243;n tanto de las caracter&#237;sticas cl&#237;nicas como histol&#243;gicas&#44; el diagn&#243;stico de esta entidad suele ser un reto cl&#237;nico&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">El ipilimumab es un anticuerpo monoclonal humano recombinante &#40;IgG1&#41; que actuar&#225; inhibiendo el ant&#237;geno asociado 4 de los linfocitos T citot&#243;xicos &#40;CTLA-4&#41;&#44; un regulador negativo de la activaci&#243;n de los linfocitos T&#44; gracias al bloqueo de su uni&#243;n a los receptores B7&#46; Esto conlleva un incremento tanto de la activaci&#243;n&#47;proliferaci&#243;n&#44; como de la producci&#243;n de la IL-2&#44; causando la amplificaci&#243;n de la respuesta inmune&#44; promoviendo as&#237; la inmunidad antitumoral<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">3&#44;4</span></a>&#46; El ipilimumab fue aprobado por la FDA para el tratamiento del melanoma irresecable o metast&#225;sico&#46; Entre los efectos adversos relacionados con el sistema inmune m&#225;s frecuentes se encuentran la colitis&#47;diarrea&#44; dermatitis<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a>&#44; hepatitis&#44; endocrinopat&#237;as&#44; blefaritis<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a>&#44; transaminitits<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a>&#44; uve&#237;tis&#44; hipofisitis<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">6</span></a>&#44; nefritis<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">7&#8211;9</span></a>&#44; tiroiditis<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a> y la miopat&#237;a inflamatoria<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">10&#8211;12</span></a>&#46; Los efectos adversos dermatol&#243;gicos observados con mayor frecuencia son el exantema morbiliforme&#44; el vit&#237;ligo y la alopecia areata<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">13</span></a>&#46; El exantema morbiliforme se presentar&#225; sobre todo a nivel del tronco y extremidades&#59; histol&#243;gicamente se observar&#225; espongiosis epid&#233;rmica&#44; edema a nivel de la dermis papilar&#44; as&#237; como un infiltrado perivascular compuesto por linfocitos y eosin&#243;filos&#44; y un predominio de linfocitos T CD4 a nivel d&#233;rmico<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">10&#44;11</span></a>&#46; Otros eventos adversos cut&#225;neos&#44; pero que se presentan con menor frecuencia son la presencia de hipopigmentaci&#243;n&#44; prurigo&#44; exantema acneiforme y liquenoide&#44; &#250;lceras simulando un pioderma gangrenoso&#44; toxicidad cut&#225;nea en &#225;reas previamente irradiadas&#44; reacciones de fotosensibilidad&#44; s&#237;ndrome DRESS<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">13</span></a>&#44; as&#237; como el s&#237;ndrome de Stevens-Johnson&#47;necr&#243;lisis epid&#233;rmica t&#243;xica<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">13</span></a>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Las reacciones granulomatosas &#171;sarcoidosis-like&#187; secundarias al tratamiento con ipilimumab cada vez se presentan con mayor frecuencia<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">12</span></a>&#46; La sarcoidosis es una entidad granulomatosa multisist&#233;mica de etiolog&#237;a desconocida&#46; Esta se suele asociar a neoplasias hematol&#243;gicas&#44; tumores s&#243;lidos y tambi&#233;n se ha descrito en relaci&#243;n con medicaci&#243;n antineopl&#225;sica&#46; La formaci&#243;n de granulomas se cree que se deber&#225; a una respuesta incontrolada de los linfocitos T helper-1 a ant&#237;genos no conocidos&#46; La sobreproducci&#243;n de IL- 2 e IFN-&#947; contribuir&#225;n adem&#225;s a que se desencadene esta reacci&#243;n<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">14</span></a>&#46; La ausencia del bloqueo de la proliferaci&#243;n de los linfocitos T&#44; por ejemplo debido al efecto anti-CTLA-4&#44; podr&#237;a justificar el desarrollo de estas lesiones granulomatosas&#44; as&#237; como ocurre con los linfocitos T autorreactivos en la sarcoidosis<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">15</span></a>&#46; El mecanismo patog&#233;nico exacto por el cual el ipilimumab induce una reacci&#243;n granulomatosa &#171;sarcoidosis-like&#187; sigue por el momento siendo una inc&#243;gnita<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">16</span></a>&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Como efecto secundario al ipilimumab ya se hab&#237;an descrito el desarrollo de lesiones granulomatosas &#171;sarcoidosis-like&#187; localizadas tanto en mediastino&#44; en pulm&#243;n&#44; as&#237; como en otras v&#237;sceras&#44;<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">5&#44;14&#44;16&#8211;24</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#59; Andersen et al&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">19</span></a> reportaron recientemente el caso de un paciente var&#243;n&#44; quien veinte meses despu&#233;s de haber iniciado tratamiento con ipilimumab&#44; present&#243; lesiones granulomatosas localizadas &#250;nicamente a nivel espl&#233;nico&#46; Sin embargo&#44; si bien existen m&#250;ltiples publicaciones acerca de lesiones granulomatosas &#171;sarcoidosis-like&#187; inducidas por ipilimumab<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">15&#44;16&#44;21&#8211;23&#44;25&#8211;29</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#44; la afectaci&#243;n exclusivamente cut&#225;nea es considerada excepcional&#46; Por otro lado&#44; a diferencia de los dem&#225;s casos publicados&#44; donde la reacci&#243;n granulomatosa se presenta en las primeras semanas o meses&#44; en nuestro paciente esta se dio de forma tard&#237;a&#44; 18 meses despu&#233;s de haber iniciado con el ipilimumab&#46; Nuestro paciente present&#243; una reacci&#243;n granulomatosa cut&#225;nea difusa&#44; 18 meses despu&#233;s de haber iniciado el tratamiento con ipilimumab&#46; La mejor&#237;a cl&#237;nica se logr&#243; solo despu&#233;s de que se suspendi&#243; el ipilimumab&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">En resumen&#44; este caso se puede considerar tanto un reto diagn&#243;stico como terap&#233;utico&#44; ya que la cl&#237;nica del paciente fue refractaria a altas dosis de corticoides y solo mejor&#243; una vez que se suspendi&#243; el ipilimumab&#46; As&#237; mismo resaltamos la importancia de un seguimiento cercano en pacientes tratados con ipilimumab&#44; ya que ha quedado demostrado el riesgo de desarrollar lesiones granulomatosas &#171;sarcoidosis-like&#187; como efecto adverso&#46; Hasta donde sabemos&#44; este es el primer caso descrito de un paciente diagnosticado de melanoma&#44; que ha presentado una reacci&#243;n granulomatosa con afectaci&#243;n exclusivamente cut&#225;nea como efecto secundario al ipilimumab&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conflicto de intereses</span><p id="par0050" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1132655"
          "titulo" => "Graphical abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:3 [
          "identificador" => "xres1132656"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        2 => array:2 [
          "identificador" => "xpalclavsec1065252"
          "titulo" => "Palabras clave"
        ]
        3 => array:3 [
          "identificador" => "xres1132654"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0015"
            ]
          ]
        ]
        4 => array:2 [
          "identificador" => "xpalclavsec1065251"
          "titulo" => "Keywords"
        ]
        5 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Caso cl&#237;nico"
        ]
        6 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Discusi&#243;n"
        ]
        7 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflicto de intereses"
        ]
        8 => array:2 [
          "identificador" => "xack385610"
          "titulo" => "Agradecimientos"
        ]
        9 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1065252"
          "palabras" => array:7 [
            0 => "Anti-CTLA 4"
            1 => "Inmunoterapia"
            2 => "Melanoma metast&#225;sico"
            3 => "Sarcoidosis"
            4 => "Reacci&#243;n granulomatosa"
            5 => "Evento adverso relacionado inmune-mediado"
            6 => "Reacci&#243;n adversa medicamentosa"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1065251"
          "palabras" => array:7 [
            0 => "Anti-CTLA4"
            1 => "Immunotherapy"
            2 => "Metastatic melanoma"
            3 => "Sarcoidosis"
            4 => "Granulomatous reaction"
            5 => "Immune-related adverse event"
            6 => "Adverse drug reaction"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Las reacciones granulomatosas &#171;sarcoidosis-like&#187; secundarias a ipilimumab afectar&#225;n simult&#225;neamente a m&#250;ltiples &#243;rganos y caracter&#237;sticamente se presentar&#225;n semanas o meses despu&#233;s de haber iniciado el tratamiento&#46; Paciente var&#243;n de 67 a&#241;os&#44; quien consulta por reacci&#243;n cut&#225;nea granulomatosa a nivel de tronco&#44; extremidades y rostro&#46; Esta se present&#243; 18 meses despu&#233;s de haber iniciado tratamiento con ipilimumab&#44; medicamento pautado por el diagn&#243;stico de un melanoma metast&#225;sico&#46; Reportamos reacci&#243;n granulomatosa de presentaci&#243;n exclusivamente cut&#225;nea&#44; como efecto adverso medicamentoso tard&#237;o secundario al tratamiento con ipilimumab&#46; As&#237; mismo resaltamos la necesidad de realizar en los pacientes tratados con ipilimumab un seguimiento prolongado&#46;</p></span>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0015" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Granulomatous sarcoidosis-like reactions affecting multiple organ systems at one time have infrequently been described within weeks to months after initiation of Ipilimumab&#46; We present the first case of a 67-year-old man with isolated cutaneous granulomatous reaction involving the trunk&#44; extremities&#44; and face after eighteen months of treatment with ipilimumab for metastatic melanoma&#46; This case documents the eruption of isolated cutaneous granulomatous reaction as a late treatment-related adverse effect of ipilimumab&#44; highlighting the importance of adequate&#44; prolonged follow-up&#46;</p></span>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1411
            "Ancho" => 1667
            "Tamanyo" => 232941
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Examen cl&#237;nico&#46; P&#225;pulas inflamatorias costrosas agrupadas y n&#243;dulos distribuidos de forma sim&#233;trica a nivel del rostro a&#41;&#44; caderas b&#41; y tobillos c&#41;&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1513
            "Ancho" => 1000
            "Tamanyo" => 528812
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Hallazgos histol&#243;gicos&#46; Adelgazamiento de la epidermis con una acantosis irregular&#44; discreta espongiosis y paraqueratosis&#46; La dermis papilar est&#225; reemplazada casi en su totalidad por granulomas a&#41;&#46; Reacci&#243;n granulomatosa con macr&#243;fagos prominentes y c&#233;lulas gigantes b&#41;&#46; &#40;Hematoxilina y eosina&#44; x10&#41;&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Fuente</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sexo</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Edad de inicio de ipilimumab</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Dosis de ipilimumab &#40;mg&#47;kg&#41;</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Neoplasia</th><th class="td" title="table-head  " colspan="4" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">&#211;rgano afectado</th></tr><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Piel&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Pulm&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Ganglios mediast&#237;nicos o hilares&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Otros&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cervantes et al&#46; &#40;2017&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Nandavaram et al&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a> &#40;2017&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">57&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Firwana et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">16</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41; y c&#225;ncer de colon &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bazo y adenopat&#237;as a nivel retroauricular&#44; occipital&#44; cervical&#44; axilar&#44; iliaco&#44; e inguinal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">42&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Adenopat&#237;a a nivel cervical&#44; axilar&#44; y retroperitoneal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Reuss et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">28</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Adenopat&#237;a a nivel cervical&#44; inguinal&#44; supraclavicular&#44; e iliaco izquierdo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Martinez Leborans et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">29</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Kim et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">21</span></a>&#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">d</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Carcinoma urotelial &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ri&#241;&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Suozzi et al&#46;<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">22</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">e</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Adenocarcinoma de pulm&#243;n &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Toumeh et al&#46;<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">23</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H&#237;gado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Anderson et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">19</span></a> &#40;2014&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bazo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Murphy et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">20</span></a> &#40;2014&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">38&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">SNC &#40;silla turca y adyacente al infund&#237;bulo de la pituitaria&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tissot et al&#46;<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">15</span></a> &#40;2013&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">57&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Reule y North<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">26</span></a> &#40;2013&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Wilgenhof et al&#46;<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">14</span></a> &#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">56&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bazo&#44; adenopat&#237;a a nivel axilar y retroperitoneal y en la base del cuello&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Berthod et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">17</span></a> &#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">66&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vogel et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">18</span></a> &#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">van den Eertwegh et al&#46;<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">24</span></a>&#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Castraci&#243;n-c&#225;ncer de pr&#243;stata resistente &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Eckert et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">25</span></a> &#40;2009&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">71&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Seve et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">27</span></a> &#40;2009&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Epitelio bronquial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1932605.png"
              ]
            ]
          ]
          "notaPie" => array:6 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado con mFOLFOX6 adyuvante e ipilimumab&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado inicialmente con ipilimumab y vermurafenib&#44; que posteriormente cambi&#243; a pembrolizumab&#46; La adenopat&#237;a se present&#243; despu&#233;s de recibir tratamiento con pembrolizumab&#46;</p>"
            ]
            2 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "c"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado con ipilimumab &#40;3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47;nivolumab&#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; en infusiones combinadas&#46;</p>"
            ]
            3 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "d"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0020"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado con ipilimumab &#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47;nivolumab&#40;3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; en infusiones combinadas&#46;</p>"
            ]
            4 => array:3 [
              "identificador" => "tblfn0025"
              "etiqueta" => "e"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0025"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>Paciente tratado con ipilimumab &#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47;nivolumab&#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; en infusiones combinadas&#46;</p>"
            ]
            5 => array:3 [
              "identificador" => "tblfn0030"
              "etiqueta" => "f"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0030"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span> Paciente tratado con ipilimumab &#40;5<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47; factor estimulante granulocito-macr&#243;fago-vacuna de c&#233;lulas de c&#225;ncer de pr&#243;stata obtenidas a trav&#233;s de transducci&#243;n alog&#233;nica &#40;GVAX&#41; en infusiones combinadas&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Casos cl&#237;nicos de reacci&#243;n granulomatosa &#171;sarcoidosis-like&#187; en pacientes con diagn&#243;stico de melanoma u otras neoplasias tratados con ipilimumab</p>"
        ]
      ]
      3 => array:5 [
        "identificador" => "fig0015"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "fx1.jpeg"
            "Alto" => 1025
            "Ancho" => 1333
            "Tamanyo" => 90988
          ]
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:29 [
            0 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A clinicopathologic approach to granulomatous dermatoses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46;O&#46; Rabinowitz"
                            1 => "M&#46;T&#46; Zaim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "1996"
                        "volumen" => "35"
                        "paginaInicial" => "588"
                        "paginaFinal" => "600"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8859289"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Granulomatous mycosis fungoides Report of two cases and review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46; Fischer"
                            1 => "J&#46; Wohlrab"
                            2 => "T&#46;H&#46; Audring"
                            3 => "W&#46; Sterry"
                            4 => "W&#46;C&#46; Marsch"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol&#46;"
                        "fecha" => "2000"
                        "volumen" => "14"
                        "paginaInicial" => "196"
                        "paginaFinal" => "202"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11032065"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Hodi FS&#44; O&#8217;Day SJ&#44; McDermott DF&#44; Weber RW&#44; Sosman JA&#44; Haanen JB&#44; et al&#46; Improved survival with ipilimumab in patients with metastatic melanoma&#46; N Engl J Med&#46; 2010&#59;363&#58;711-23&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab&#58; a novel treatment for metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46;E&#46; Culver"
                            1 => "M&#46;L&#46; Gatesman"
                            2 => "E&#46;E&#46; Mancl"
                            3 => "D&#46;K&#46; Lowe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1345/aph.1P651"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother&#46;"
                        "fecha" => "2011"
                        "volumen" => "45"
                        "paginaInicial" => "510"
                        "paginaFinal" => "519"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21505108"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced sarcoidosis and thyroiditis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46; Nandavaram"
                            1 => "A&#46; Nadkarni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Am J Ther&#46;"
                        "fecha" => "2017"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced hypophysitis in melanoma patients&#58; an Australian case series"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Lam"
                            1 => "M&#46;M&#46; Chan"
                            2 => "A&#46;N&#46; Sweeting"
                            3 => "S&#46;M&#46; De Sousa"
                            4 => "A&#46; Clements"
                            5 => "M&#46;S&#46; Carlino"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/imj.12819"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intern Med J&#46;"
                        "fecha" => "2015"
                        "volumen" => "45"
                        "paginaInicial" => "1066"
                        "paginaFinal" => "1073"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26010858"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab granulomatous interstitial nephritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Thajudeen"
                            1 => "M&#46; Madhrira"
                            2 => "E&#46; Bracamonte"
                            3 => "L&#46;D&#46; Cranmer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J&#46; Ther"
                        "fecha" => "2015"
                        "volumen" => "22"
                        "paginaInicial" => "e84"
                        "paginaFinal" => "e87"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Kidney injuries related to ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Izzedine"
                            1 => "V&#46; Gueutin"
                            2 => "C&#46; Gharbi"
                            3 => "C&#46; Mateus"
                            4 => "C&#46; Robert"
                            5 => "E&#46; Routier"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10637-014-0092-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Invest New Drugs&#46;"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "769"
                        "paginaFinal" => "773"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24687600"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0305"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Acute interstitial nephritis related to immune checkpoint inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Belliere"
                            1 => "N&#46; Meyer"
                            2 => "J&#46; Mazieres"
                            3 => "S&#46; Ollier"
                            4 => "S&#46; Boulinguez"
                            5 => "A&#46; Delas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/bjc.2016.358"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Cancer&#46;"
                        "fecha" => "2016"
                        "volumen" => "115"
                        "paginaInicial" => "1457"
                        "paginaFinal" => "1461"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27832664"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46;M&#46; Di Giacomo"
                            1 => "M&#46; Biagioli"
                            2 => "M&#46; Maio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.seminoncol.2010.09.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Semin Oncol&#46;"
                        "fecha" => "2010"
                        "volumen" => "37"
                        "paginaInicial" => "499"
                        "paginaFinal" => "507"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21074065"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous adverse effects of the immune checkpoint inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "L&#46;K&#46; Collins"
                            1 => "M&#46;S&#46; Chapman"
                            2 => "J&#46;B&#46; Carter"
                            3 => "F&#46;H&#46; Samie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Curr Probl Cancer&#46;"
                        "fecha" => "2016"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse events associated with immune checkpoint blockade in patients with cancer&#58; A systematic review of case reports"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N&#46; Abdel-Wahab"
                            1 => "M&#46; Shah"
                            2 => "M&#46;E&#46; Suarez-Almazor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0160221"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLoS One&#46;"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "paginaInicial" => "e0160221"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27472273"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0310"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The price of tumor control&#58; an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;J&#46; Voskens"
                            1 => "S&#46;M&#46; Goldinger"
                            2 => "C&#46; Loquai"
                            3 => "C&#46; Robert"
                            4 => "K&#46;C&#46; Kaehler"
                            5 => "C&#46; Berking"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "PLoS One&#46;"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "e53745"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0315"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Wilgenhof"
                            1 => "V&#46; Morlion"
                            2 => "A&#46;C&#46; Seghers"
                            3 => "S&#46; Du Four"
                            4 => "E&#46; Vanderlinden"
                            5 => "S&#46; Hanon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Anticancer Res&#46;"
                        "fecha" => "2012"
                        "volumen" => "32"
                        "paginaInicial" => "1355"
                        "paginaFinal" => "1359"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22493370"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46; Tissot"
                            1 => "A&#46; Carsin"
                            2 => "N&#46; Freymond"
                            3 => "Y&#46; Pacheco"
                            4 => "G&#46; Devouassoux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00107912"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J&#46;"
                        "fecha" => "2013"
                        "volumen" => "41"
                        "paginaInicial" => "246"
                        "paginaFinal" => "247"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23277525"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "B&#46; Firwana"
                            1 => "R&#46; Ravilla"
                            2 => "M&#46; Raval"
                            3 => "L&#46; Hutchins"
                            4 => "F&#46; Mahmoud"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "J Oncol Pharm Pract&#46;"
                        "fecha" => "2016"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0320"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pulmonary sarcoid-like granulomatosis induced by ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Berthod"
                            1 => "R&#46; Lazor"
                            2 => "I&#46; Letovanec"
                            3 => "E&#46; Romano"
                            4 => "L&#46; Noirez"
                            5 => "J&#46; Mazza Stalder"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2011.39.3298"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol&#46;"
                        "fecha" => "2012"
                        "volumen" => "30"
                        "paginaInicial" => "e156"
                        "paginaFinal" => "e159"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22547608"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46;V&#46; Vogel"
                            1 => "A&#46; Guislain"
                            2 => "P&#46; Kvistborg"
                            3 => "T&#46;N&#46; Schumacher"
                            4 => "J&#46;B&#46; Haanen"
                            5 => "C&#46;U&#46; Blank"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2011.37.9693"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol&#46;"
                        "fecha" => "2012"
                        "volumen" => "30"
                        "paginaInicial" => "e7"
                        "paginaFinal" => "e10"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22124094"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46; Andersen"
                            1 => "P&#46; Norgaard"
                            2 => "M&#46;K&#46; Al-Jailawi"
                            3 => "I&#46;M&#46; Svane"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Oncoimmunology&#46;"
                        "fecha" => "2014"
                        "volumen" => "3"
                        "paginaInicial" => "e06"
                        "paginaFinal" => "e9545"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "K&#46;P&#46; Murphy"
                            1 => "M&#46;P&#46; Kennedy"
                            2 => "J&#46;E&#46; Barry"
                            3 => "K&#46;N&#46; O&#8217;Regan"
                            4 => "D&#46;G&#46; Power"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000362614"
                      "Revista" => array:6 [
                        "tituloSerie" => "Oncol Res Treat"
                        "fecha" => "2014"
                        "volumen" => "37"
                        "paginaInicial" => "351"
                        "paginaFinal" => "353"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24903767"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "C&#46; Kim"
                            1 => "J&#46; Gao"
                            2 => "V&#46;R&#46; Shannon"
                            3 => "A&#46; Siefker-Radtke"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bcr-2015-212769"
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ Case Rep&#46;"
                        "fecha" => "2016"
                        "volumen" => "2016"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26783007"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0325"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;C&#46; Suozzi"
                            1 => "M&#46; Stahl"
                            2 => "C&#46;J&#46; Ko"
                            3 => "A&#46; Chiang"
                            4 => "S&#46;N&#46; Gettinger"
                            5 => "M&#46;D&#46; Siegel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdcr.2016.05.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAAD Case Rep&#46;"
                        "fecha" => "2016"
                        "volumen" => "2"
                        "paginaInicial" => "264"
                        "paginaFinal" => "268"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27486590"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced granulomatous disease occurring simultaneously with disease progression in a patient with metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Toumeh"
                            1 => "R&#46; Sakhi"
                            2 => "S&#46; Shah"
                            3 => "S&#46;K&#46; Arudra"
                            4 => "L&#46;E&#46; de Las Casas"
                            5 => "R&#46;T&#46; Skeel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MJT.0000000000000266"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Ther&#46;"
                        "fecha" => "2016"
                        "volumen" => "23"
                        "paginaInicial" => "e1068"
                        "paginaFinal" => "e1071"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25933140"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0330"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer&#58; a phase 1 dose-escalation trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;J&#46; van den Eertwegh"
                            1 => "J&#46; Versluis"
                            2 => "H&#46;P&#46; van den Berg"
                            3 => "S&#46;J&#46; Santegoets"
                            4 => "R&#46;J&#46; van Moorselaar"
                            5 => "T&#46;M&#46; van der Sluis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1470-2045(12)70007-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Oncol&#46;"
                        "fecha" => "2012"
                        "volumen" => "13"
                        "paginaInicial" => "509"
                        "paginaFinal" => "517"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22326922"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Eckert"
                            1 => "A&#46; Schoeffler"
                            2 => "S&#46; Dalle"
                            3 => "A&#46; Phan"
                            4 => "L&#46; Kiakouama"
                            5 => "L&#46; Thomas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000161122"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatology&#46;"
                        "fecha" => "2009"
                        "volumen" => "218"
                        "paginaInicial" => "69"
                        "paginaFinal" => "70"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18832811"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;B&#46; Reule"
                            1 => "J&#46;P&#46; North"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2013.07.028"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2013"
                        "volumen" => "69"
                        "paginaInicial" => "e272"
                        "paginaFinal" => "e273"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24124863"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis and melanoma&#58; a referral center study of 1&#44;199 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "P&#46; Seve"
                            1 => "A&#46;M&#46; Schott"
                            2 => "M&#46; Pavic"
                            3 => "C&#46; Broussolle"
                            4 => "L&#46; Gilis"
                            5 => "L&#46; Thomas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000213245"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatology&#46;"
                        "fecha" => "2009"
                        "volumen" => "219"
                        "paginaInicial" => "25"
                        "paginaFinal" => "31"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19365109"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy&#58; a case report &#38; review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;E&#46; Reuss"
                            1 => "P&#46;R&#46; Kunk"
                            2 => "A&#46;M&#46; Stowman"
                            3 => "A&#46;A&#46; Gru"
                            4 => "C&#46;L&#46; Slingluff Jr&#46;"
                            5 => "E&#46;M&#46; Gaughan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "J Immunother Cancer&#46;"
                        "fecha" => "2016"
                        "volumen" => "4"
                        "paginaInicial" => "94"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "L&#46; Martinez Leborans"
                            1 => "A&#46; Esteve Martinez"
                            2 => "A&#46;M&#46; Victoria Martinez"
                            3 => "V&#46; Alegre de Miquel"
                            4 => "A&#46; Berrocal Jaime"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/dth.12380"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatol Ther&#46;"
                        "fecha" => "2016"
                        "volumen" => "29"
                        "paginaInicial" => "306"
                        "paginaFinal" => "308"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27357143"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack385610"
        "titulo" => "Agradecimientos"
        "texto" => "<p id="par0055" class="elsevierStylePara elsevierViewall">Al paciente por autorizarnos publicar este caso&#46; As&#237; mismo al Dr&#46; George W&#46; Elgart&#44; del Departamento de Dermatolog&#237;a y Cirug&#237;a Cut&#225;nea&#44; Facultad de Medicina de la Universidad Miller de Miami&#44; quien nos apoy&#243; con las im&#225;genes histopatol&#243;gicas y al Dr&#46; Sadegh Amini del Departamento de Dermatolog&#237;a y Cirug&#237;a Cut&#225;nea&#44; Facultad de Medicina de la Universidad Miller de Miami&#44; quien nos ayud&#243; con este caso&#46; Subrayamos que no han recibido otra gratificaci&#243;n por dicha contribuci&#243;n&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011000000001/v1_201901030610/S0001731018303454/v1_201901030610/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "76882"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Comunicaciones Breves"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011000000001/v1_201901030610/S0001731018303454/v1_201901030610/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018303454?idApp=UINPBA000044"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

COMUNICACIÓN BREVE
Reacción granulomatosa en paciente con melanoma metastásico tratado con ipilimumab: primer caso descrito presentando clínica cutánea únicamente
Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab: First Case Reported With Isolated Cutaneous Findings
J. Cervantesa,
Autor para correspondencia
J.Cervantes1@umiami.edu

Autor para correspondencia.
, A. Rosena, L. Dehesab, G. Dickinsonc, J. Alonso-Llamazaresa
a Departamento de Dermatología y Cirugía Cutánea, Facultad de Medicina, Universidad Miller de Miami, Miami, Florida, Estados Unidos
b Centro Médico San Francisco, Universidad de California, San Francisco, California, Estados Unidos
c Departamento de Enfermedades Infecciosas, Facultad de Medicina, Universidad Miller de Miami, Miami, Florida, Estados Unidos
Leído
7720
Veces
se ha leído el artículo
2700
Total PDF
5020
Total HTML
Compartir estadísticas
 array:24 [
  "pii" => "S0001731018303454"
  "issn" => "00017310"
  "doi" => "10.1016/j.ad.2017.11.021"
  "estado" => "S300"
  "fechaPublicacion" => "2019-01-01"
  "aid" => "2026"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2018"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2019;110:43-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 343
    "formatos" => array:2 [
      "HTML" => 157
      "PDF" => 186
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S1578219018304116"
      "issn" => "15782190"
      "doi" => "10.1016/j.adengl.2018.11.013"
      "estado" => "S300"
      "fechaPublicacion" => "2019-01-01"
      "aid" => "2026"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2019;110:43-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2
        "HTML" => 2
      ]
      "en" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Brief Comunication</span>"
        "titulo" => "Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab&#58; First Case Reported With Isolated Cutaneous Findings"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "43"
            "paginaFinal" => "49"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Reacci&#243;n granulomatosa en paciente con melanoma metast&#225;sico tratado con ipilimumab&#58; primer caso descrito presentando cl&#237;nica cut&#225;nea &#250;nicamente"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Figure 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 1513
                "Ancho" => 1000
                "Tamanyo" => 528812
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Pathology findings&#46; Epidermal thinning with irregular acanthosis&#44; discrete spongiosis&#44; and parakeratosis&#46; The papillary dermis is replaced almost entirely by granulomas &#40;A&#41; and granulomatous reaction with prominent macrophages and giant cells &#40;B&#41;&#46; &#40;Hematoxylin and eosin&#44; x10&#46;&#41;&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "J&#46; Cervantes, A&#46; Rosen, L&#46; Dehesa, G&#46; Dickinson, J&#46; Alonso-Llamazares"
            "autores" => array:5 [
              0 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Cervantes"
              ]
              1 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Rosen"
              ]
              2 => array:2 [
                "nombre" => "L&#46;"
                "apellidos" => "Dehesa"
              ]
              3 => array:2 [
                "nombre" => "G&#46;"
                "apellidos" => "Dickinson"
              ]
              4 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Alonso-Llamazares"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S0001731018303454"
          "doi" => "10.1016/j.ad.2017.11.021"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018303454?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304116?idApp=UINPBA000044"
      "url" => "/15782190/0000011000000001/v1_201901030631/S1578219018304116/v1_201901030631/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0001731017306051"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2017.06.024"
    "estado" => "S300"
    "fechaPublicacion" => "2019-01-01"
    "aid" => "1849"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2019;110:50-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 343
      "formatos" => array:2 [
        "HTML" => 144
        "PDF" => 199
      ]
    ]
    "es" => array:14 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">COMUNICACI&#211;N BREVE</span>"
      "titulo" => "Epiderm&#243;lisis bullosa distr&#243;fica recesiva y embarazo"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:3 [
        0 => "es"
        1 => "es"
        2 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "50"
          "paginaFinal" => "52"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Recessive Dystrophic Epidermolysis Bullosa and Pregnancy"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 1
        "multimedia" => array:5 [
          "identificador" => "fig0015"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => false
          "mostrarDisplay" => true
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "fx1.jpeg"
              "Alto" => 514
              "Ancho" => 1333
              "Tamanyo" => 124894
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F&#46; Boria, R&#46; Maseda, M&#46; Mart&#237;n-Came&#225;n, M&#46; De la Calle, R&#46; de Lucas"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Boria"
            ]
            1 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "Maseda"
            ]
            2 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Mart&#237;n-Came&#225;n"
            ]
            3 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "De la Calle"
            ]
            4 => array:2 [
              "nombre" => "R&#46;"
              "apellidos" => "de Lucas"
            ]
          ]
        ]
      ]
      "resumen" => array:1 [
        0 => array:3 [
          "titulo" => "Graphical abstract"
          "clase" => "graphical"
          "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>"
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219018304001"
        "doi" => "10.1016/j.adengl.2018.11.004"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304001?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306051?idApp=UINPBA000044"
    "url" => "/00017310/0000011000000001/v1_201901030610/S0001731017306051/v1_201901030610/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0001731018303971"
    "issn" => "00017310"
    "doi" => "10.1016/j.ad.2018.09.003"
    "estado" => "S300"
    "fechaPublicacion" => "2019-01-01"
    "aid" => "2050"
    "copyright" => "AEDV"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2019;110:38-42"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1088
      "formatos" => array:2 [
        "HTML" => 310
        "PDF" => 778
      ]
    ]
    "es" => array:14 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">ORIGINAL</span>"
      "titulo" => "Aislamiento de <span class="elsevierStyleItalic">Haemophilus</span> spp&#46; en exudados uretrales como posible agente etiol&#243;gico de uretritis aguda&#58; estudio de 38 casos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:3 [
        0 => "es"
        1 => "es"
        2 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "38"
          "paginaFinal" => "42"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "<span class="elsevierStyleItalic">Haemophilus</span> Species Isolated in Urethral Exudates as a Possible Causative Agent in Acute Urethritis&#58; A Study of 38 Cases"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 1
        "multimedia" => array:5 [
          "identificador" => "fig0015"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => false
          "mostrarDisplay" => true
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "fx1.jpeg"
              "Alto" => 1085
              "Ancho" => 1315
              "Tamanyo" => 71523
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46; Magdaleno-Tapial, C&#46; Valenzuela-O&#241;ate, M&#46;M&#46; Giacaman-von der Weth, B&#46; Ferrer-Guill&#233;n, &#193;&#46; Mart&#237;nez-Domenech, M&#46; Garc&#237;a-Legaz Mart&#237;nez, J&#46;M&#46; Ortiz-Salvador, D&#46; Subiabre-Ferrer, P&#46; Hern&#225;ndez-Bel"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Magdaleno-Tapial"
            ]
            1 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Valenzuela-O&#241;ate"
            ]
            2 => array:2 [
              "nombre" => "M&#46;M&#46;"
              "apellidos" => "Giacaman-von der Weth"
            ]
            3 => array:2 [
              "nombre" => "B&#46;"
              "apellidos" => "Ferrer-Guill&#233;n"
            ]
            4 => array:2 [
              "nombre" => "&#193;&#46;"
              "apellidos" => "Mart&#237;nez-Domenech"
            ]
            5 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Garc&#237;a-Legaz Mart&#237;nez"
            ]
            6 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Ortiz-Salvador"
            ]
            7 => array:2 [
              "nombre" => "D&#46;"
              "apellidos" => "Subiabre-Ferrer"
            ]
            8 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Hern&#225;ndez-Bel"
            ]
          ]
        ]
      ]
      "resumen" => array:1 [
        0 => array:3 [
          "titulo" => "Graphical abstract"
          "clase" => "graphical"
          "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>"
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S1578219018304098"
        "doi" => "10.1016/j.adengl.2018.11.011"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018304098?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018303971?idApp=UINPBA000044"
    "url" => "/00017310/0000011000000001/v1_201901030610/S0001731018303971/v1_201901030610/es/main.assets"
  ]
  "es" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">COMUNICACI&#211;N BREVE</span>"
    "titulo" => "Reacci&#243;n granulomatosa en paciente con melanoma metast&#225;sico tratado con ipilimumab&#58; primer caso descrito presentando cl&#237;nica cut&#225;nea &#250;nicamente"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "43"
        "paginaFinal" => "49"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "J&#46; Cervantes, A&#46; Rosen, L&#46; Dehesa, G&#46; Dickinson, J&#46; Alonso-Llamazares"
        "autores" => array:5 [
          0 => array:4 [
            "nombre" => "J&#46;"
            "apellidos" => "Cervantes"
            "email" => array:1 [
              0 => "J&#46;Cervantes1&#64;umiami&#46;edu"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "Rosen"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "L&#46;"
            "apellidos" => "Dehesa"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "G&#46;"
            "apellidos" => "Dickinson"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "J&#46;"
            "apellidos" => "Alonso-Llamazares"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Departamento de Dermatolog&#237;a y Cirug&#237;a Cut&#225;nea&#44; Facultad de Medicina&#44; Universidad Miller de Miami&#44; Miami&#44; Florida&#44; Estados Unidos"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Centro M&#233;dico San Francisco&#44; Universidad de California&#44; San Francisco&#44; California&#44; Estados Unidos"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Departamento de Enfermedades Infecciosas&#44; Facultad de Medicina&#44; Universidad Miller de Miami&#44; Miami&#44; Florida&#44; Estados Unidos"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Granulomatous Reaction in a Patient With Metastatic Melanoma Treated With Ipilimumab&#58; First Case Reported With Isolated Cutaneous Findings"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 1
      "multimedia" => array:5 [
        "identificador" => "fig0015"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "fx1.jpeg"
            "Alto" => 1025
            "Ancho" => 1333
            "Tamanyo" => 90988
          ]
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Caso cl&#237;nico</span><p id="par0005" class="elsevierStylePara elsevierViewall">Un var&#243;n de 67 a&#241;os acudi&#243; a la consulta de dermatolog&#237;a por prurito generalizado de leve intensidad de seis meses de evoluci&#243;n&#44; acompa&#241;ado de m&#250;ltiples lesiones papulosas&#44; coalescentes&#44; localizadas inicialmente en espalda&#44; pero que posteriormente se extienden r&#225;pidamente hacia rostro&#44; extremidades superiores e inferiores&#44; dorso de manos y pies&#44; ingle y caderas&#46; Entre los antecedentes patol&#243;gicos cabe mencionar el diagn&#243;stico de melanoma metast&#225;sico &#40;estadio IV&#41;&#46; El tumor primario hab&#237;a sido diagnosticado en la piel lumbar&#44; y adem&#225;s el paciente presentaba met&#225;stasis en el pulm&#243;n&#44; el h&#237;gado y en ganglios linf&#225;ticos retroperitoneales&#46; Gracias al tratamiento con ipilulumab el paciente se encontraba en remisi&#243;n completa desde hac&#237;a dos a&#241;os&#46; El ipilimumab se paut&#243; inicialmente a altas dosis &#40;10<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; cada 3 semanas por 4 ciclos &#40;fase de inducci&#243;n&#41; y posteriormente se pas&#243; a pauta de una infusi&#243;n cada 3 meses &#40;fase de mantenimiento&#41;&#46; El paciente present&#243; sequedad&#44; alopecia y vit&#237;ligo como efectos adversos en relaci&#243;n con el ipilimumab&#59; todos fueron de primer grado&#44; por lo que no fue necesario disminuir la dosis&#46; Adem&#225;s del ipilimumab&#44; el paciente se encontraba en tratamiento con venlafaxina&#44; olmesart&#225;n&#44; fexofenadina y ranitidina&#46; No se conoc&#237;a la existencia de alguna alergia medicamentosa&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Al examen cl&#237;nico se evidenciaron m&#250;ltiples p&#225;pulas inflamatorias agrupadas&#44; de aspecto costroso&#44; distribuidas sim&#233;tricamente a nivel de rostro &#40;a predominio de surcos nasolabiales&#44; arcos supraciliares y glabela&#41; &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>a&#41;&#44; as&#237; como en cuello&#44; orejas&#44; cuero cabelludo&#44; ingles&#44; espalda&#44; caderas &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>b&#41;&#44; codos&#44; mu&#241;ecas y tobillos &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>c&#41;&#46; Anal&#237;ticamente&#44; tanto la bioqu&#237;mica sangu&#237;nea&#44; el hemograma&#44; el calcio urinario&#44; como la ECA&#44; se encontraban dentro de la normalidad&#46; Los cultivos para micobacterias&#44; bacterias y hongos fueron negativos&#44; as&#237; como el PPD y el RPR&#46; Tanto la radiograf&#237;a de t&#243;rax como el PET-TAC no mostraban hallazgos patol&#243;gicos&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Se decidi&#243; biopsiar las lesiones&#46; La histopatolog&#237;a mostraba a nivel de dermis superficial la presencia de granulomas nodulares epitelioides rodeados por linfocitos T&#46; Por otro lado se evidenciaban &#225;reas con epidermotropismo linfoc&#237;tico&#44; compatibles con una dermatitis granulomatosa &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a> a y b&#41;&#46; Se objetivaban escasos linfocitos B CD20 positivo&#44; y el CD30&#44; CD56&#44; CD1a y S100 fueron negativos&#46; El CD58 fue positivo para c&#233;lulas gigantes y de igual forma para algunos macr&#243;fagos&#46; La mayor&#237;a de los linfocitos del infiltrado se marcaban con CD3&#44; CD4 y CD7&#46; La relaci&#243;n CD4&#58;CD8 fue de 2&#58;1&#46; PAS&#44; GMS&#44; giemsa&#44; gram y Fite fueron negativos&#46; Tinciones espec&#237;ficas para treponema de igual forma fueron negativas&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Ante los hallazgos cl&#237;nicos e histol&#243;gicos se lleg&#243; al diagn&#243;stico de una dermatitis granulomatosa secundaria al ipilimumab&#46; Se inici&#243; tratamiento con prednisona v&#237;a oral&#44; a una dosis de 60<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; con lo que el paciente mejor&#243; inicialmente&#46; Sin embargo&#44; tras pauta descendente de predmisona&#44; las lesiones empeoraron&#46; Se pautaron corticoides v&#237;a intramuscular y t&#243;pica&#44; con lo que el paciente present&#243; una mejor&#237;a cl&#237;nica relativa&#46; En consenso con oncolog&#237;a&#44; se decide suspender el tratamiento con ipilimumab&#46; Seis meses despu&#233;s de haber suspendido el tratamiento&#44; las lesiones cut&#225;neas se resolvieron completamente&#46; No fue necesario pautar medicaci&#243;n complementaria&#46; En el &#250;ltimo control&#44; el paciente se encontraba asintom&#225;tico y bajo seguimiento tanto por oncolog&#237;a como por dermatolog&#237;a con la finalidad de detectar precozmente la presencia de recidiva tumoral&#59; para lo cual se realiza un PET-TAC cada tres meses as&#237; como visitas de seguimiento cada tres a seis meses&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discusi&#243;n</span><p id="par0025" class="elsevierStylePara elsevierViewall">Las dermatosis granulomatosas se caracterizan por presentar un infiltrado inflamatorio predominantemente d&#233;rmico&#44; reactivo&#44; no neopl&#225;sico&#44; compuesto principalmente por macr&#243;fagos tisulares &#40;histiocitos&#41;&#44; c&#233;lulas epitelioides&#44; as&#237; como por c&#233;lulas gigantes multinucleadas<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">1</span></a>&#46; Los granulomas de etiolog&#237;a no infecciosa se pueden observar en el granuloma anular&#44; el granuloma anular elastol&#237;tico de c&#233;lulas gigantes&#44; la necrobiosis lipo&#237;dica&#44; la dermatitis granulomatosa intersticial&#44; la reacci&#243;n granulomatosa intersticial medicamentosa&#44; la sarcoidosis&#44; las reacciones a cuerpo extra&#241;o&#44; as&#237; como en neoplasias malignas &#40;ej&#46; micosis fungoides&#44; s&#237;ndrome de S&#233;zary&#44; enfermedad de Hodgkin&#44; leucemia linf&#225;tica cr&#243;nica B&#44; melanoma y otras neoplasias &#91;pulm&#243;n&#44; mama&#44; etc&#46;&#93;&#41; entre otras<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">2</span></a>&#46; Debido a la superposici&#243;n tanto de las caracter&#237;sticas cl&#237;nicas como histol&#243;gicas&#44; el diagn&#243;stico de esta entidad suele ser un reto cl&#237;nico&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">El ipilimumab es un anticuerpo monoclonal humano recombinante &#40;IgG1&#41; que actuar&#225; inhibiendo el ant&#237;geno asociado 4 de los linfocitos T citot&#243;xicos &#40;CTLA-4&#41;&#44; un regulador negativo de la activaci&#243;n de los linfocitos T&#44; gracias al bloqueo de su uni&#243;n a los receptores B7&#46; Esto conlleva un incremento tanto de la activaci&#243;n&#47;proliferaci&#243;n&#44; como de la producci&#243;n de la IL-2&#44; causando la amplificaci&#243;n de la respuesta inmune&#44; promoviendo as&#237; la inmunidad antitumoral<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">3&#44;4</span></a>&#46; El ipilimumab fue aprobado por la FDA para el tratamiento del melanoma irresecable o metast&#225;sico&#46; Entre los efectos adversos relacionados con el sistema inmune m&#225;s frecuentes se encuentran la colitis&#47;diarrea&#44; dermatitis<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a>&#44; hepatitis&#44; endocrinopat&#237;as&#44; blefaritis<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a>&#44; transaminitits<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a>&#44; uve&#237;tis&#44; hipofisitis<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">6</span></a>&#44; nefritis<a class="elsevierStyleCrossRefs" href="#bib0180"><span class="elsevierStyleSup">7&#8211;9</span></a>&#44; tiroiditis<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a> y la miopat&#237;a inflamatoria<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">10&#8211;12</span></a>&#46; Los efectos adversos dermatol&#243;gicos observados con mayor frecuencia son el exantema morbiliforme&#44; el vit&#237;ligo y la alopecia areata<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">13</span></a>&#46; El exantema morbiliforme se presentar&#225; sobre todo a nivel del tronco y extremidades&#59; histol&#243;gicamente se observar&#225; espongiosis epid&#233;rmica&#44; edema a nivel de la dermis papilar&#44; as&#237; como un infiltrado perivascular compuesto por linfocitos y eosin&#243;filos&#44; y un predominio de linfocitos T CD4 a nivel d&#233;rmico<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">10&#44;11</span></a>&#46; Otros eventos adversos cut&#225;neos&#44; pero que se presentan con menor frecuencia son la presencia de hipopigmentaci&#243;n&#44; prurigo&#44; exantema acneiforme y liquenoide&#44; &#250;lceras simulando un pioderma gangrenoso&#44; toxicidad cut&#225;nea en &#225;reas previamente irradiadas&#44; reacciones de fotosensibilidad&#44; s&#237;ndrome DRESS<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">13</span></a>&#44; as&#237; como el s&#237;ndrome de Stevens-Johnson&#47;necr&#243;lisis epid&#233;rmica t&#243;xica<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">13</span></a>&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Las reacciones granulomatosas &#171;sarcoidosis-like&#187; secundarias al tratamiento con ipilimumab cada vez se presentan con mayor frecuencia<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">12</span></a>&#46; La sarcoidosis es una entidad granulomatosa multisist&#233;mica de etiolog&#237;a desconocida&#46; Esta se suele asociar a neoplasias hematol&#243;gicas&#44; tumores s&#243;lidos y tambi&#233;n se ha descrito en relaci&#243;n con medicaci&#243;n antineopl&#225;sica&#46; La formaci&#243;n de granulomas se cree que se deber&#225; a una respuesta incontrolada de los linfocitos T helper-1 a ant&#237;genos no conocidos&#46; La sobreproducci&#243;n de IL- 2 e IFN-&#947; contribuir&#225;n adem&#225;s a que se desencadene esta reacci&#243;n<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">14</span></a>&#46; La ausencia del bloqueo de la proliferaci&#243;n de los linfocitos T&#44; por ejemplo debido al efecto anti-CTLA-4&#44; podr&#237;a justificar el desarrollo de estas lesiones granulomatosas&#44; as&#237; como ocurre con los linfocitos T autorreactivos en la sarcoidosis<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">15</span></a>&#46; El mecanismo patog&#233;nico exacto por el cual el ipilimumab induce una reacci&#243;n granulomatosa &#171;sarcoidosis-like&#187; sigue por el momento siendo una inc&#243;gnita<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">16</span></a>&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Como efecto secundario al ipilimumab ya se hab&#237;an descrito el desarrollo de lesiones granulomatosas &#171;sarcoidosis-like&#187; localizadas tanto en mediastino&#44; en pulm&#243;n&#44; as&#237; como en otras v&#237;sceras&#44;<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">5&#44;14&#44;16&#8211;24</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#59; Andersen et al&#46;<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">19</span></a> reportaron recientemente el caso de un paciente var&#243;n&#44; quien veinte meses despu&#233;s de haber iniciado tratamiento con ipilimumab&#44; present&#243; lesiones granulomatosas localizadas &#250;nicamente a nivel espl&#233;nico&#46; Sin embargo&#44; si bien existen m&#250;ltiples publicaciones acerca de lesiones granulomatosas &#171;sarcoidosis-like&#187; inducidas por ipilimumab<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">15&#44;16&#44;21&#8211;23&#44;25&#8211;29</span></a> &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabla 1</a>&#41;&#44; la afectaci&#243;n exclusivamente cut&#225;nea es considerada excepcional&#46; Por otro lado&#44; a diferencia de los dem&#225;s casos publicados&#44; donde la reacci&#243;n granulomatosa se presenta en las primeras semanas o meses&#44; en nuestro paciente esta se dio de forma tard&#237;a&#44; 18 meses despu&#233;s de haber iniciado con el ipilimumab&#46; Nuestro paciente present&#243; una reacci&#243;n granulomatosa cut&#225;nea difusa&#44; 18 meses despu&#233;s de haber iniciado el tratamiento con ipilimumab&#46; La mejor&#237;a cl&#237;nica se logr&#243; solo despu&#233;s de que se suspendi&#243; el ipilimumab&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">En resumen&#44; este caso se puede considerar tanto un reto diagn&#243;stico como terap&#233;utico&#44; ya que la cl&#237;nica del paciente fue refractaria a altas dosis de corticoides y solo mejor&#243; una vez que se suspendi&#243; el ipilimumab&#46; As&#237; mismo resaltamos la importancia de un seguimiento cercano en pacientes tratados con ipilimumab&#44; ya que ha quedado demostrado el riesgo de desarrollar lesiones granulomatosas &#171;sarcoidosis-like&#187; como efecto adverso&#46; Hasta donde sabemos&#44; este es el primer caso descrito de un paciente diagnosticado de melanoma&#44; que ha presentado una reacci&#243;n granulomatosa con afectaci&#243;n exclusivamente cut&#225;nea como efecto secundario al ipilimumab&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conflicto de intereses</span><p id="par0050" class="elsevierStylePara elsevierViewall">Los autores declaran no tener ning&#250;n conflicto de intereses&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres1132655"
          "titulo" => "Graphical abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:3 [
          "identificador" => "xres1132656"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        2 => array:2 [
          "identificador" => "xpalclavsec1065252"
          "titulo" => "Palabras clave"
        ]
        3 => array:3 [
          "identificador" => "xres1132654"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0015"
            ]
          ]
        ]
        4 => array:2 [
          "identificador" => "xpalclavsec1065251"
          "titulo" => "Keywords"
        ]
        5 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Caso cl&#237;nico"
        ]
        6 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Discusi&#243;n"
        ]
        7 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflicto de intereses"
        ]
        8 => array:2 [
          "identificador" => "xack385610"
          "titulo" => "Agradecimientos"
        ]
        9 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1065252"
          "palabras" => array:7 [
            0 => "Anti-CTLA 4"
            1 => "Inmunoterapia"
            2 => "Melanoma metast&#225;sico"
            3 => "Sarcoidosis"
            4 => "Reacci&#243;n granulomatosa"
            5 => "Evento adverso relacionado inmune-mediado"
            6 => "Reacci&#243;n adversa medicamentosa"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1065251"
          "palabras" => array:7 [
            0 => "Anti-CTLA4"
            1 => "Immunotherapy"
            2 => "Metastatic melanoma"
            3 => "Sarcoidosis"
            4 => "Granulomatous reaction"
            5 => "Immune-related adverse event"
            6 => "Adverse drug reaction"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Las reacciones granulomatosas &#171;sarcoidosis-like&#187; secundarias a ipilimumab afectar&#225;n simult&#225;neamente a m&#250;ltiples &#243;rganos y caracter&#237;sticamente se presentar&#225;n semanas o meses despu&#233;s de haber iniciado el tratamiento&#46; Paciente var&#243;n de 67 a&#241;os&#44; quien consulta por reacci&#243;n cut&#225;nea granulomatosa a nivel de tronco&#44; extremidades y rostro&#46; Esta se present&#243; 18 meses despu&#233;s de haber iniciado tratamiento con ipilimumab&#44; medicamento pautado por el diagn&#243;stico de un melanoma metast&#225;sico&#46; Reportamos reacci&#243;n granulomatosa de presentaci&#243;n exclusivamente cut&#225;nea&#44; como efecto adverso medicamentoso tard&#237;o secundario al tratamiento con ipilimumab&#46; As&#237; mismo resaltamos la necesidad de realizar en los pacientes tratados con ipilimumab un seguimiento prolongado&#46;</p></span>"
      ]
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0015" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Granulomatous sarcoidosis-like reactions affecting multiple organ systems at one time have infrequently been described within weeks to months after initiation of Ipilimumab&#46; We present the first case of a 67-year-old man with isolated cutaneous granulomatous reaction involving the trunk&#44; extremities&#44; and face after eighteen months of treatment with ipilimumab for metastatic melanoma&#46; This case documents the eruption of isolated cutaneous granulomatous reaction as a late treatment-related adverse effect of ipilimumab&#44; highlighting the importance of adequate&#44; prolonged follow-up&#46;</p></span>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1411
            "Ancho" => 1667
            "Tamanyo" => 232941
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Examen cl&#237;nico&#46; P&#225;pulas inflamatorias costrosas agrupadas y n&#243;dulos distribuidos de forma sim&#233;trica a nivel del rostro a&#41;&#44; caderas b&#41; y tobillos c&#41;&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1513
            "Ancho" => 1000
            "Tamanyo" => 528812
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Hallazgos histol&#243;gicos&#46; Adelgazamiento de la epidermis con una acantosis irregular&#44; discreta espongiosis y paraqueratosis&#46; La dermis papilar est&#225; reemplazada casi en su totalidad por granulomas a&#41;&#46; Reacci&#243;n granulomatosa con macr&#243;fagos prominentes y c&#233;lulas gigantes b&#41;&#46; &#40;Hematoxilina y eosina&#44; x10&#41;&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Fuente</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sexo</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Edad de inicio de ipilimumab</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Dosis de ipilimumab &#40;mg&#47;kg&#41;</th><th class="td" title="table-head  " rowspan="2" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Neoplasia</th><th class="td" title="table-head  " colspan="4" align="left" valign="top" scope="col" style="border-bottom: 2px solid black">&#211;rgano afectado</th></tr><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Piel&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Pulm&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Ganglios mediast&#237;nicos o hilares&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Otros&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cervantes et al&#46; &#40;2017&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Nandavaram et al&#46;<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">5</span></a> &#40;2017&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">57&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Firwana et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">16</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41; y c&#225;ncer de colon &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bazo y adenopat&#237;as a nivel retroauricular&#44; occipital&#44; cervical&#44; axilar&#44; iliaco&#44; e inguinal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">42&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Adenopat&#237;a a nivel cervical&#44; axilar&#44; y retroperitoneal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Reuss et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">28</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Adenopat&#237;a a nivel cervical&#44; inguinal&#44; supraclavicular&#44; e iliaco izquierdo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Martinez Leborans et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">29</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Kim et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">21</span></a>&#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">d</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Carcinoma urotelial &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ri&#241;&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Suozzi et al&#46;<a class="elsevierStyleCrossRef" href="#bib0325"><span class="elsevierStyleSup">22</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">60&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">e</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Adenocarcinoma de pulm&#243;n &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Toumeh et al&#46;<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">23</span></a> &#40;2016&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H&#237;gado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Anderson et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">19</span></a> &#40;2014&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bazo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Murphy et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">20</span></a> &#40;2014&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">38&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">SNC &#40;silla turca y adyacente al infund&#237;bulo de la pituitaria&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tissot et al&#46;<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">15</span></a> &#40;2013&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">57&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Reule y North<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">26</span></a> &#40;2013&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">55&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio III&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Wilgenhof et al&#46;<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">14</span></a> &#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">56&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bazo&#44; adenopat&#237;a a nivel axilar y retroperitoneal y en la base del cuello&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Berthod et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">17</span></a> &#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">66&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vogel et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">18</span></a> &#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">van den Eertwegh et al&#46;<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">24</span></a>&#40;2012&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Castraci&#243;n-c&#225;ncer de pr&#243;stata resistente &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Eckert et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">25</span></a> &#40;2009&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">71&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Seve et al<span class="elsevierStyleItalic">&#46;</span><a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">27</span></a> &#40;2009&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Femenino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No informado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Melanoma &#40;Estadio IV&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">X&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Epitelio bronquial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1932605.png"
              ]
            ]
          ]
          "notaPie" => array:6 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado con mFOLFOX6 adyuvante e ipilimumab&#46;</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado inicialmente con ipilimumab y vermurafenib&#44; que posteriormente cambi&#243; a pembrolizumab&#46; La adenopat&#237;a se present&#243; despu&#233;s de recibir tratamiento con pembrolizumab&#46;</p>"
            ]
            2 => array:3 [
              "identificador" => "tblfn0015"
              "etiqueta" => "c"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0015"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado con ipilimumab &#40;3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47;nivolumab&#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; en infusiones combinadas&#46;</p>"
            ]
            3 => array:3 [
              "identificador" => "tblfn0020"
              "etiqueta" => "d"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0020"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>paciente tratado con ipilimumab &#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47;nivolumab&#40;3<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; en infusiones combinadas&#46;</p>"
            ]
            4 => array:3 [
              "identificador" => "tblfn0025"
              "etiqueta" => "e"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0025"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span>Paciente tratado con ipilimumab &#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47;nivolumab&#40;1<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41; en infusiones combinadas&#46;</p>"
            ]
            5 => array:3 [
              "identificador" => "tblfn0030"
              "etiqueta" => "f"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0030"><span class="elsevierStyleHsp" style=""></span>&#58;<span class="elsevierStyleHsp" style=""></span> Paciente tratado con ipilimumab &#40;5<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#41;&#47; factor estimulante granulocito-macr&#243;fago-vacuna de c&#233;lulas de c&#225;ncer de pr&#243;stata obtenidas a trav&#233;s de transducci&#243;n alog&#233;nica &#40;GVAX&#41; en infusiones combinadas&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Casos cl&#237;nicos de reacci&#243;n granulomatosa &#171;sarcoidosis-like&#187; en pacientes con diagn&#243;stico de melanoma u otras neoplasias tratados con ipilimumab</p>"
        ]
      ]
      3 => array:5 [
        "identificador" => "fig0015"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "fx1.jpeg"
            "Alto" => 1025
            "Ancho" => 1333
            "Tamanyo" => 90988
          ]
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:29 [
            0 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A clinicopathologic approach to granulomatous dermatoses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46;O&#46; Rabinowitz"
                            1 => "M&#46;T&#46; Zaim"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "1996"
                        "volumen" => "35"
                        "paginaInicial" => "588"
                        "paginaFinal" => "600"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8859289"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Granulomatous mycosis fungoides Report of two cases and review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "M&#46; Fischer"
                            1 => "J&#46; Wohlrab"
                            2 => "T&#46;H&#46; Audring"
                            3 => "W&#46; Sterry"
                            4 => "W&#46;C&#46; Marsch"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol&#46;"
                        "fecha" => "2000"
                        "volumen" => "14"
                        "paginaInicial" => "196"
                        "paginaFinal" => "202"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11032065"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Hodi FS&#44; O&#8217;Day SJ&#44; McDermott DF&#44; Weber RW&#44; Sosman JA&#44; Haanen JB&#44; et al&#46; Improved survival with ipilimumab in patients with metastatic melanoma&#46; N Engl J Med&#46; 2010&#59;363&#58;711-23&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab&#58; a novel treatment for metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46;E&#46; Culver"
                            1 => "M&#46;L&#46; Gatesman"
                            2 => "E&#46;E&#46; Mancl"
                            3 => "D&#46;K&#46; Lowe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1345/aph.1P651"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother&#46;"
                        "fecha" => "2011"
                        "volumen" => "45"
                        "paginaInicial" => "510"
                        "paginaFinal" => "519"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21505108"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced sarcoidosis and thyroiditis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S&#46; Nandavaram"
                            1 => "A&#46; Nadkarni"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Am J Ther&#46;"
                        "fecha" => "2017"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0295"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced hypophysitis in melanoma patients&#58; an Australian case series"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Lam"
                            1 => "M&#46;M&#46; Chan"
                            2 => "A&#46;N&#46; Sweeting"
                            3 => "S&#46;M&#46; De Sousa"
                            4 => "A&#46; Clements"
                            5 => "M&#46;S&#46; Carlino"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/imj.12819"
                      "Revista" => array:6 [
                        "tituloSerie" => "Intern Med J&#46;"
                        "fecha" => "2015"
                        "volumen" => "45"
                        "paginaInicial" => "1066"
                        "paginaFinal" => "1073"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26010858"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab granulomatous interstitial nephritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Thajudeen"
                            1 => "M&#46; Madhrira"
                            2 => "E&#46; Bracamonte"
                            3 => "L&#46;D&#46; Cranmer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J&#46; Ther"
                        "fecha" => "2015"
                        "volumen" => "22"
                        "paginaInicial" => "e84"
                        "paginaFinal" => "e87"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0300"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Kidney injuries related to ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "H&#46; Izzedine"
                            1 => "V&#46; Gueutin"
                            2 => "C&#46; Gharbi"
                            3 => "C&#46; Mateus"
                            4 => "C&#46; Robert"
                            5 => "E&#46; Routier"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10637-014-0092-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Invest New Drugs&#46;"
                        "fecha" => "2014"
                        "volumen" => "32"
                        "paginaInicial" => "769"
                        "paginaFinal" => "773"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24687600"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0305"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Acute interstitial nephritis related to immune checkpoint inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Belliere"
                            1 => "N&#46; Meyer"
                            2 => "J&#46; Mazieres"
                            3 => "S&#46; Ollier"
                            4 => "S&#46; Boulinguez"
                            5 => "A&#46; Delas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/bjc.2016.358"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Cancer&#46;"
                        "fecha" => "2016"
                        "volumen" => "115"
                        "paginaInicial" => "1457"
                        "paginaFinal" => "1461"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27832664"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46;M&#46; Di Giacomo"
                            1 => "M&#46; Biagioli"
                            2 => "M&#46; Maio"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.seminoncol.2010.09.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "Semin Oncol&#46;"
                        "fecha" => "2010"
                        "volumen" => "37"
                        "paginaInicial" => "499"
                        "paginaFinal" => "507"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21074065"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous adverse effects of the immune checkpoint inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "L&#46;K&#46; Collins"
                            1 => "M&#46;S&#46; Chapman"
                            2 => "J&#46;B&#46; Carter"
                            3 => "F&#46;H&#46; Samie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Curr Probl Cancer&#46;"
                        "fecha" => "2016"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse events associated with immune checkpoint blockade in patients with cancer&#58; A systematic review of case reports"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N&#46; Abdel-Wahab"
                            1 => "M&#46; Shah"
                            2 => "M&#46;E&#46; Suarez-Almazor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0160221"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLoS One&#46;"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "paginaInicial" => "e0160221"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27472273"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0310"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The price of tumor control&#58; an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;J&#46; Voskens"
                            1 => "S&#46;M&#46; Goldinger"
                            2 => "C&#46; Loquai"
                            3 => "C&#46; Robert"
                            4 => "K&#46;C&#46; Kaehler"
                            5 => "C&#46; Berking"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "PLoS One&#46;"
                        "fecha" => "2013"
                        "volumen" => "8"
                        "paginaInicial" => "e53745"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0315"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-CTLA-4 monoclonal antibody and selective BRAF inhibitor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Wilgenhof"
                            1 => "V&#46; Morlion"
                            2 => "A&#46;C&#46; Seghers"
                            3 => "S&#46; Du Four"
                            4 => "E&#46; Vanderlinden"
                            5 => "S&#46; Hanon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Anticancer Res&#46;"
                        "fecha" => "2012"
                        "volumen" => "32"
                        "paginaInicial" => "1355"
                        "paginaFinal" => "1359"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22493370"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46; Tissot"
                            1 => "A&#46; Carsin"
                            2 => "N&#46; Freymond"
                            3 => "Y&#46; Pacheco"
                            4 => "G&#46; Devouassoux"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00107912"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J&#46;"
                        "fecha" => "2013"
                        "volumen" => "41"
                        "paginaInicial" => "246"
                        "paginaFinal" => "247"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23277525"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "B&#46; Firwana"
                            1 => "R&#46; Ravilla"
                            2 => "M&#46; Raval"
                            3 => "L&#46; Hutchins"
                            4 => "F&#46; Mahmoud"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "J Oncol Pharm Pract&#46;"
                        "fecha" => "2016"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0320"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pulmonary sarcoid-like granulomatosis induced by ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Berthod"
                            1 => "R&#46; Lazor"
                            2 => "I&#46; Letovanec"
                            3 => "E&#46; Romano"
                            4 => "L&#46; Noirez"
                            5 => "J&#46; Mazza Stalder"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2011.39.3298"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol&#46;"
                        "fecha" => "2012"
                        "volumen" => "30"
                        "paginaInicial" => "e156"
                        "paginaFinal" => "e159"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22547608"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced sarcoidosis in a patient with metastatic melanoma undergoing complete remission"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "W&#46;V&#46; Vogel"
                            1 => "A&#46; Guislain"
                            2 => "P&#46; Kvistborg"
                            3 => "T&#46;N&#46; Schumacher"
                            4 => "J&#46;B&#46; Haanen"
                            5 => "C&#46;U&#46; Blank"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1200/JCO.2011.37.9693"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Oncol&#46;"
                        "fecha" => "2012"
                        "volumen" => "30"
                        "paginaInicial" => "e7"
                        "paginaFinal" => "e10"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22124094"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46; Andersen"
                            1 => "P&#46; Norgaard"
                            2 => "M&#46;K&#46; Al-Jailawi"
                            3 => "I&#46;M&#46; Svane"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Oncoimmunology&#46;"
                        "fecha" => "2014"
                        "volumen" => "3"
                        "paginaInicial" => "e06"
                        "paginaFinal" => "e9545"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "K&#46;P&#46; Murphy"
                            1 => "M&#46;P&#46; Kennedy"
                            2 => "J&#46;E&#46; Barry"
                            3 => "K&#46;N&#46; O&#8217;Regan"
                            4 => "D&#46;G&#46; Power"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000362614"
                      "Revista" => array:6 [
                        "tituloSerie" => "Oncol Res Treat"
                        "fecha" => "2014"
                        "volumen" => "37"
                        "paginaInicial" => "351"
                        "paginaFinal" => "353"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24903767"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "C&#46; Kim"
                            1 => "J&#46; Gao"
                            2 => "V&#46;R&#46; Shannon"
                            3 => "A&#46; Siefker-Radtke"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/bcr-2015-212769"
                      "Revista" => array:4 [
                        "tituloSerie" => "BMJ Case Rep&#46;"
                        "fecha" => "2016"
                        "volumen" => "2016"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26783007"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0325"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;C&#46; Suozzi"
                            1 => "M&#46; Stahl"
                            2 => "C&#46;J&#46; Ko"
                            3 => "A&#46; Chiang"
                            4 => "S&#46;N&#46; Gettinger"
                            5 => "M&#46;D&#46; Siegel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdcr.2016.05.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAAD Case Rep&#46;"
                        "fecha" => "2016"
                        "volumen" => "2"
                        "paginaInicial" => "264"
                        "paginaFinal" => "268"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27486590"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ipilimumab-induced granulomatous disease occurring simultaneously with disease progression in a patient with metastatic melanoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Toumeh"
                            1 => "R&#46; Sakhi"
                            2 => "S&#46; Shah"
                            3 => "S&#46;K&#46; Arudra"
                            4 => "L&#46;E&#46; de Las Casas"
                            5 => "R&#46;T&#46; Skeel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MJT.0000000000000266"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Ther&#46;"
                        "fecha" => "2016"
                        "volumen" => "23"
                        "paginaInicial" => "e1068"
                        "paginaFinal" => "e1071"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25933140"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0330"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer&#58; a phase 1 dose-escalation trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;J&#46; van den Eertwegh"
                            1 => "J&#46; Versluis"
                            2 => "H&#46;P&#46; van den Berg"
                            3 => "S&#46;J&#46; Santegoets"
                            4 => "R&#46;J&#46; van Moorselaar"
                            5 => "T&#46;M&#46; van der Sluis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S1470-2045(12)70007-4"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet Oncol&#46;"
                        "fecha" => "2012"
                        "volumen" => "13"
                        "paginaInicial" => "509"
                        "paginaFinal" => "517"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22326922"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Eckert"
                            1 => "A&#46; Schoeffler"
                            2 => "S&#46; Dalle"
                            3 => "A&#46; Phan"
                            4 => "L&#46; Kiakouama"
                            5 => "L&#46; Thomas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000161122"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatology&#46;"
                        "fecha" => "2009"
                        "volumen" => "218"
                        "paginaInicial" => "69"
                        "paginaFinal" => "70"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18832811"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;B&#46; Reule"
                            1 => "J&#46;P&#46; North"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2013.07.028"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol&#46;"
                        "fecha" => "2013"
                        "volumen" => "69"
                        "paginaInicial" => "e272"
                        "paginaFinal" => "e273"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24124863"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis and melanoma&#58; a referral center study of 1&#44;199 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "P&#46; Seve"
                            1 => "A&#46;M&#46; Schott"
                            2 => "M&#46; Pavic"
                            3 => "C&#46; Broussolle"
                            4 => "L&#46; Gilis"
                            5 => "L&#46; Thomas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000213245"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatology&#46;"
                        "fecha" => "2009"
                        "volumen" => "219"
                        "paginaInicial" => "25"
                        "paginaFinal" => "31"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19365109"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy&#58; a case report &#38; review of the literature"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;E&#46; Reuss"
                            1 => "P&#46;R&#46; Kunk"
                            2 => "A&#46;M&#46; Stowman"
                            3 => "A&#46;A&#46; Gru"
                            4 => "C&#46;L&#46; Slingluff Jr&#46;"
                            5 => "E&#46;M&#46; Gaughan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "J Immunother Cancer&#46;"
                        "fecha" => "2016"
                        "volumen" => "4"
                        "paginaInicial" => "94"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "L&#46; Martinez Leborans"
                            1 => "A&#46; Esteve Martinez"
                            2 => "A&#46;M&#46; Victoria Martinez"
                            3 => "V&#46; Alegre de Miquel"
                            4 => "A&#46; Berrocal Jaime"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/dth.12380"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatol Ther&#46;"
                        "fecha" => "2016"
                        "volumen" => "29"
                        "paginaInicial" => "306"
                        "paginaFinal" => "308"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27357143"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack385610"
        "titulo" => "Agradecimientos"
        "texto" => "<p id="par0055" class="elsevierStylePara elsevierViewall">Al paciente por autorizarnos publicar este caso&#46; As&#237; mismo al Dr&#46; George W&#46; Elgart&#44; del Departamento de Dermatolog&#237;a y Cirug&#237;a Cut&#225;nea&#44; Facultad de Medicina de la Universidad Miller de Miami&#44; quien nos apoy&#243; con las im&#225;genes histopatol&#243;gicas y al Dr&#46; Sadegh Amini del Departamento de Dermatolog&#237;a y Cirug&#237;a Cut&#225;nea&#44; Facultad de Medicina de la Universidad Miller de Miami&#44; quien nos ayud&#243; con este caso&#46; Subrayamos que no han recibido otra gratificaci&#243;n por dicha contribuci&#243;n&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/00017310/0000011000000001/v1_201901030610/S0001731018303454/v1_201901030610/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "76882"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Comunicaciones Breves"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/0000011000000001/v1_201901030610/S0001731018303454/v1_201901030610/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018303454?idApp=UINPBA000044"
]
Información del artículo
ISSN: 00017310
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 11 8 19
2024 Octubre 75 36 111
2024 Septiembre 62 23 85
2024 Agosto 83 61 144
2024 Julio 87 43 130
2024 Junio 111 70 181
2024 Mayo 103 49 152
2024 Abril 93 44 137
2024 Marzo 92 46 138
2024 Febrero 92 41 133
2024 Enero 77 36 113
2023 Diciembre 100 35 135
2023 Noviembre 86 58 144
2023 Octubre 101 51 152
2023 Septiembre 97 75 172
2023 Agosto 90 28 118
2023 Julio 92 74 166
2023 Junio 73 39 112
2023 Mayo 79 54 133
2023 Abril 56 38 94
2023 Marzo 83 31 114
2023 Febrero 60 31 91
2023 Enero 64 34 98
2022 Diciembre 78 47 125
2022 Noviembre 102 61 163
2022 Octubre 156 39 195
2022 Septiembre 92 68 160
2022 Agosto 70 59 129
2022 Julio 87 70 157
2022 Junio 86 42 128
2022 Mayo 97 60 157
2022 Abril 121 24 145
2022 Marzo 135 57 192
2022 Febrero 156 62 218
2022 Enero 152 75 227
2021 Diciembre 98 55 153
2021 Noviembre 107 53 160
2021 Octubre 65 69 134
2021 Septiembre 62 34 96
2021 Agosto 47 53 100
2021 Julio 47 28 75
2021 Junio 66 26 92
2021 Mayo 248 53 301
2021 Abril 140 66 206
2021 Marzo 105 52 157
2021 Febrero 79 30 109
2021 Enero 68 34 102
2020 Diciembre 49 25 74
2020 Noviembre 59 18 77
2020 Octubre 77 37 114
2020 Septiembre 55 32 87
2020 Agosto 34 29 63
2020 Julio 53 22 75
2020 Junio 65 32 97
2020 Mayo 50 40 90
2020 Abril 46 27 73
2020 Marzo 38 24 62
2020 Febrero 8 9 17
2020 Enero 1 6 7
2019 Diciembre 2 17 19
2019 Noviembre 3 6 9
2019 Octubre 5 6 11
2019 Septiembre 6 10 16
2019 Agosto 3 5 8
2019 Julio 1 7 8
2019 Junio 0 18 18
2019 Mayo 5 30 35
2019 Abril 13 2 15
2019 Marzo 11 8 19
2019 Febrero 46 32 78
2019 Enero 53 29 82
2018 Diciembre 1 0 1
2018 Noviembre 5 7 12
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?